CIK 0001625101
- Non-accelerated filer
- Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465696597
- Phone
- +1 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-23 | UECKER DARRIN Chief Technology Officer | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +20,000 | $4.00 | $80K | 142,872 |
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −20,000 | $16.21 | $324K | 122,872 |
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +61,534 | $4.00 | $246K | 184,406 |
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +100,000 | $4.00 | $400K | 284,406 |
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −20,000 | 61,534 | ||
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −61,534 | 0 | ||
| 2025-09-17 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −100,000 | 0 | ||
| 2025-09-16 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-16 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $16.28 | $407K | 122,872 |
| 2025-09-16 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −25,000 | 81,534 | ||
| 2025-09-15 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-15 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $15.77 | $394K | 122,872 |
| 2025-09-15 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −25,000 | 106,534 | ||
| 2025-09-12 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-12 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $14.32 | $358K | 122,872 |
| 2025-09-12 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −25,000 | 131,534 | ||
| 2025-09-11 | UECKER DARRIN Chief Technology Officer | Exercise or conversion 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-11 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $14.78 | $370K | 122,872 |
| 2025-09-11 | UECKER DARRIN Chief Technology Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −25,000 | 156,534 |
Page 1 of 3 · 42 trades